We have evaluated intracellular pH (pHi) and Na+/H+ exchanger activity in peripheral lymphocytes from 16 patients on regular acetate hemodialysis. All the patients were taking oral NaHCO3 supplementation (30 mmol/day), to maintain predialysis arterial blood acid-base status within normal range (pH 7.36 ± 0.02, PHCO3- 23.3 ± 1.2 mM, pC02 40.9 ± 1.4 mm Hg). pHi was measured, using the fluorescent probe BCECF (2’,7’-bis-carboxyethyl-5,6-carboxyfluorescein), both in nominal absence of bicarbonate (Hepes solution, pH 7.4; n = 10) and in the presence of HCO3-/CO2 buffer system (pH 7.4, [HCO3-] 25 mM, PCO2 40 mm Hg; n = 6). Predialysis pHi did not differ from controls when measured in the presence of HCO3-/CO2 (7.28 ± 0.04 vs. 7.29 ± 0.04, p = NS), but was lower in dialysis patients than in normal subjects (7.11 ± 0.04 and 7.20 ± 0.02, respectively; p < 0.05) when measured in Hepes solution. This suggested that bicarbonate-independent pHi regulation was abnormal in dialysis patients. To further characterize this abnormality of pHi regulation, lymphocytes were exposed to ethylisopropylamiloride, a specific Na+/H+ antiporter inhibitor, in Hepes solution; this maneuver induced a significantly lower decrement in pHi (0.04 ± 0.04 vs. 0.15 ± 0.03, p < 0.05) in dialysis patients than in controls, indicating reduced Na+/H+ exchanger activity in the patients. The rate of pHi recovery during the first 30 s after induction of various degrees of cell acidification (pHi range 6.2-7.0), which in the absence of HCO3-/CO2 is dependent on Na+/H+exchanger activity, was also reduced in the patients as compared to controls (p < 0.001). These findings demonstrate depressed Na+/H+ exchanger activity in lymphocytes from patients on chronic maintenance hemodialysis; accounting for the lower pHi in Hepes solution. However, this abnormality does not prevent pHi to be mainteined in the normal range in the presence of the physiological buffer HCO3-/CO2 and possibly in vivo.